Abstract:Background: Non-small cell lung cancer (NSCLC) accounts for 85 % of all lung cancers, the leading cause of cancer-related deaths worldwide. Despite recent advancements in NSCLC treatment, such as targeted therapy and immunotherapy, a large proportion of NSCLC patients develop drug resistance. Thus, development of new effective treatments for NSCLC is urgently needed. Traditional Chinese medicine may provide sources for developing new anti-cancer drugs. Although Scutellaria baicalensis (SB) has been proven to have anti-cancer effects, its action mechanism on NSCLC is not yet fully understood. Here we used network pharmacology to investigate the potential mechanism of SB treating NSCLC. Methods: We identified the active constituents of SB from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and predicted their potential targets using the SwissTargetPrediction database. Next, therapeutic targets for NSCLC were screened using five databases: GeneCards, DisGeNET, DrugBank, Online Mendelian Inheritance in Man (OMIM), and Therapeutic Target Database (TTD). A protein-protein interaction (PPI) network of the common targets between SB and NSCLC was constructed using STRING were visualized using Cytoscape. We also performed enrichment analysis of these targets to identify gene ontology (GO) and KEGG pathways associated with them. Finally, we conducted molecular docking analysis using Autodock Vina and PyMOL to investigate the interactions between active SB components and NSCLC targets. Furthermore, we performed in vitro experimental validations of the findings by bioinformatics analysis. Results: We identified 35 active compounds of SB and their 463 potential targets, and 1,073 NSCLC-associated targets. A total of 140 targets overlapped between the SB and NSCLC targets. PPI network analysis and drug-ingredient-target network analysis identified SRC, HSP90AA1, STAT3, AKT1, and MAPK3 as the core target proteins, and baicalein, 5,7,2,5-tetrahydroxy-8,6-dimethoxyflavone, skullcapflavone II, tenaxin I, and rivularin as critical active compounds of SB. GO and pathway enrichment analysis uncovered pathways significantly associated with the common targets between SB and NSCLC, including PI3K-Akt signaling, VEGF, and EGFR tyrosine kinase inhibitor resistance. Molecular docking revealed a stable binding between the main active components and core targets. In vitro experiments showed that baicalein suppressed A549 cell proliferation in a concentration-dependent manner, induced apoptosis, and caused cell cycle arrest in the S phase. Moreover, baicalein inhibited A549 cell migration and activation of the PI3K/Akt pathway. Conclusions: SB has a potential to treat NSCLC through multiple targets and pathways. This study afforded potential targets for further experimental research to explore the mechanism of SB in the treatment of NSCLC.

Scutellaria barbata and Hedyotis diffusa herb pair for breast cancer treatment: Potential mechanism based on network pharmacology

Ethyl Acetate Fraction from Hedyotis Diffusa Plus Scutellaria Barbata Inhibits the Progression of Breast Cancer via Targeting LMO1 and AKT/Mtor Signaling Pathway

Network Pharmacology and Molecular Docking Integrated Strategy to the Screening of Active Components and Mechanisms of Stephaniae Tetrandrae Radix on Breast Cancer

Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway

Antitumor Effects and the Compatibility Mechanisms of Herb Pair Scleromitrion Diffusum (willd.) R. J. Wang–Sculellaria Barbata D. Don

Mechanism of Shashen-Maidong herb pair in treating hepatocellular carcinoma using network pharmacology and experimental validation

Network-based pharmacology-based research on the effect and mechanism of the Hedyotis diffusa–Scutellaria Barbata pair in the treatment of hepatocellular carcinoma

Study on the mechanism of action of Scutellaria barbata on hepatocellular carcinoma based on network pharmacology and bioinformatics

Exploration of the effect and mechanism of Scutellaria barbata D. Don in the treatment of ovarian cancer based on network pharmacology and in vitro experimental verification

Molecular Targets and Mechanisms of Hedyotis diffusa- Scutellaria barbata Herb Pair for the Treatment of Colorectal Cancer Based on Network Pharmacology and Molecular Docking

The Use of Network Pharmacology to Investigate the Mechanism of Action of Scutellaria Barbata in the Treatment of Prostate Cancer

Exploring Targets and Related Mechanisms of Scutellaria Baicalensis for Treating Non-Small Cell Lung Cancer Based on Network Pharmacology

High-Throughput In Vitro Gene Expression Profile to Screen of Natural Herbals for Breast Cancer Treatment

Exploration of the Potential Mechanism of Tao Hong Si Wu Decoction for the Treatment of Breast Cancer Based on Network Pharmacology and In Vitro Experimental Verification

Mechanism exploration and prognosis study of Astragali Radix-Spreading hedyotis herb for the treatment of lung adenocarcinoma based on bioinformatics approaches and molecular dynamics simulation

Exploring Mechanism of Key Chinese Herbal Medicine on Breast Cancer by Data Mining and Network Pharmacology Methods

Nanoparticles Derived from Scutellaria Barbata and Hedytois Diffusa Herb Pair and Their Anti-Cancer Activity

Hedyotis diffusa Combined with Scutellaria barbata Are the Core Treatment of Chinese Herbal Medicine Used for Breast Cancer Patients: A Population-Based Study

Investigating the Mechanism of Scutellariae barbata Herba in the Treatment of Colorectal Cancer by Network Pharmacology and Molecular Docking

The Modulatory Properties of Astragalus membranaceus Treatment on Triple-Negative Breast Cancer: An Integrated Pharmacological Method

Evaluation of the Mechanism of Yishan Formula in Treating Breast Cancer Based on Network Pharmacology and Experimental Verification